A CHKA–PML autophagy checkpoint enables tumors to evade glutamine starvation
Proceedings of the National Academy of Sciences · 24.03.2026 · 123 (12)
DOI: 10.1073/pnas.2523253123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 19.03.2026. Verfasst von Ruijie Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Institute of People's Hospital of Zhengzhou University, State Key Laboratory of Metabolic Dysregulation and Prevention and Tre…. Hauptthemen laut MEDLINE: Glutamine, Autophagy, Promyelocytic Leukemia Protein, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Glutamine metabolism is essential for tumor cell proliferation and biosynthesis. However, solid tumors often face chronic glutamine deprivation, and the underlying adaptive mechanisms remain incompletely understood. Here, we show that glutamine scarcity upregulates choline kinase alpha (CHKA), whose monomerization enhances its noncanonical protein kinase activity. CHKA phosphorylates promyelocytic leukemia (PML) at tyrosine 339, promoting its cytoplasmic localization. Notably, this reflects a compartment-specific switch in PML activity: while nuclear PML facilitates protein degradation through Small Ubiquitin-like Modifier (SUMO)-ubiquitin cascades, cytoplasmic PML acts oppositely to block degradation. Specifically, cytoplasmic PML then induces SUMOylation of WD Repeat Domain Phosphoinositide-Interacting Protein 2 (WIPI2) at lysines 281 and 283, thereby blocking HUWE1-mediated ubiquitination and proteasomal degradation. Stabilized WIPI2 increases autophagic flux, supporting tumor cell survival under metabolic stress. This study identifies a critical CHKA–PML–WIPI2 axis mediating adaptation to glutamine deprivation, providing insight into metabolic plasticity and a potential therapeutic target for glutamine-dependent cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research Institute of People's Hospital of Zhengzhou University, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedica…
- School of Clinical Medicine, Henan University, Zhengzhou 450046, China.
- The Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Department of Pharmacology, School of Basic Medicine, Zhengzhou University, Zhengzhou, Henan 450001, China.
- College of Pharmaceutical Sciences, Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou 310058, China.
- School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW 2308, Australia.
ORCID-Profile: Qichen Wu, Hongxiang Li, Suhua Gao, Jinming Li, Lei Jin, Mian Wu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Wang, R., Cao, L., He, X., Thorne, R. F., Wu, Q., Ding, C., Zhang, J., Li, M., Shi, Z., Dong, X., Li, J., Li, H., Gao, S., Li, J., Zhang, X. D., Jin, L., Fan, T., & Wu, M. (2026). A CHKA–PML autophagy checkpoint enables tumors to evade glutamine starvation. Proceedings of the National Academy of Sciences, 123(12). https://doi.org/10.1073/pnas.2523253123
Vancouver
Wang R, Cao L, He X, Thorne RF, Wu Q, Ding C, et al. A CHKA–PML autophagy checkpoint enables tumors to evade glutamine starvation. Proceedings of the National Academy of Sciences. 2026;123(12). doi:10.1073/pnas.2523253123
BibTeX
@article{Wang2026,
author = {Wang, Ruijie and Cao, Leixi and He, Xianwei and Thorne, Rick Francis and Wu, Qichen and Ding, Caoyuan and Zhang, Jinjing and Li, Mengfan and Shi, Zeyuan and Dong, Xinyi and Li, Jing and Li, Hongxiang and Gao, Suhua and Li, Jinming and Zhang, Xu Dong and Jin, Lei and Fan, Tianli and Wu, Mian},
title = {A CHKA–PML autophagy checkpoint enables tumors to evade glutamine starvation},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {12},
doi = {10.1073/pnas.2523253123}
}
EUVIMED